Nucleolar prominence as a diagnostic variable in prostatic carcinoma.

Area of Science:

• Uropathology
• Oncology
• Diagnostic Cytology

Background:

• Diagnosing well-differentiated prostate adenocarcinoma on needle biopsies presents challenges.
• Nucleolar prominence is a potential diagnostic marker, but objective evaluation is limited.

Purpose of the Study:

• To identify objective nucleolar criteria for differentiating benign prostate conditions from well-differentiated prostate adenocarcinoma.
• To assess the utility of nucleolar prominence measurements in prostate cancer diagnosis.

Main Methods:

• Analysis of 41 open prostatectomy specimens (25 adenocarcinoma, 16 BPH).
• Examination of carcinoma, prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH), nodular hyperplasia, and normal prostate tissue.
• Quantification of nucleolar prominence using N' (total nuclei with nucleoli ≥ 3 μm), N'/N (fraction of nuclei with nucleoli ≥ 3 μm), and AVG (average diameter of nucleoli ≥ 3 μm).

Main Results:

• Carcinoma tissues showed significantly higher N', N'/N, and AVG values compared to hyperplastic and normal tissues (P < 0.005).
• Hyperplastic tissues had higher N' and N'/N than normal tissues (P < 0.005).
• PIN tissues had significantly greater N' and N'/N values than AAH tissues (P < 0.0001).
• The N'/N ratio was consistently above 0.31 in hyperplastic or normal tissues, with only rare exceptions in cancer/PIN areas.
• AVG did not significantly improve diagnostic discrimination between groups.

Conclusions:

• The N'/N ratio is a valuable and objective metric for diagnosing well-differentiated prostate adenocarcinoma, particularly in small tissue samples.
• This quantitative approach enhances diagnostic accuracy in challenging prostate biopsy cases.